Drug-coated balloons versus drug-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention: an updated meta-analysis with trial sequential analysis
Abstract Background Drug-coated balloons (DCBs) are an established strategy for coronary artery disease.However, the new generation drug-eluting stent (DES) is recommended for patients with Acute myocardial infarction (AMI) for coronary artery revascularization.Our aim is to provide a comprehensive appraisal of the efficacy of DCBs in patients with